Device Trial Radar · NCT02448160
Alfapump-albumin Replacement Therapy
Last checked: Nov 19, 2026Latest source record: Apr 9, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
10
Planned (sponsor's estimate)
Start
Jan 2016
Primary completion
Dec 2017
Study completion Dec 2017
Sponsor
- Lead sponsor
- Sequana Medical N.V.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 19, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will be a single centre, open-label trial. The patients will have a diagnosis of refractory ascites and will meet specified inclusion/exclusion criteria Informed consent will be obtained from all patients. All patients will have an alfapump surgically inserted and in addition will receive 8g of salt-poor Human Albumin Solution (20%) per 1 litre of Ascites drained. This Intravenous administration will be intermittent (every month) and will take place as a day patient. Patients will also receive standard of care, which may include, but is not limited to, administration of diuretics, paracentesis and consideration for orthotopic liver transplantation.
Conditions
- Liver Cirrhosis
Interventions
alfapumpDevice
Implantation of alfapump
salt-poor Human Albumin solutionDrug
Patients implanted with an alfapump will receive intermittent salt-poor human albumin solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess whether intermittent human albumin replacement in accordance with large volume paracentesis guidelines (8g/L ascites drained) can prevent the development of renal dysfunction, measured by serum creatinineTime frame: 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Royal Free Hospital
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.